Dr Richard L Tomacari, DO | |
420 W Magnetic St, Suite Er, Marquette, MI 49855-2711 | |
(888) 674-0854 | |
(906) 225-3370 |
Full Name | Dr Richard L Tomacari |
---|---|
Gender | Male |
Speciality | General Practice |
Location | 420 W Magnetic St, Marquette, Michigan |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437132065 | NPI | - | NPPES |
5101009132 | Other | MI | MICHIGAN LICENSE NUMBER |
3348283 | Medicaid | MI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 5101009132 (Michigan) | Secondary |
208D00000X | General Practice | 5101009132 (Michigan) | Primary |
Entity Name | Dlp Marquette Physician Practices Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1487902995 PECOS PAC ID: 9931359601 Enrollment ID: O20121016000312 |
News Archive
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
A study from the University of Minnesota Cancer Center indicates that overweight and obesity could more than double an older woman's risk of acute myelogenous leukemia (AML), an often fatal cancer of the bone marrow and blood.
A new survey carried out by the Royal Pharmaceutical Society and the UK Black Pharmacists Association has found that pharmacy teams are still not receiving adequate individual COVID-19 risk assessments.
Findings by UT Southwestern Medical Center researchers encourage men to weigh both the potential benefits and side effects of the drug finasteride before taking it to prevent prostate cancer.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Richard L Tomacari, DO 4602 Dept, Carol Stream, IL 60122-0021 Ph: (906) 225-4821 | Dr Richard L Tomacari, DO 420 W Magnetic St, Suite Er, Marquette, MI 49855-2711 Ph: (888) 674-0854 |
News Archive
Altor BioScience Corporation announced today that the National Heart Lung and Blood Institute has awarded Altor a Small Business Innovation Research Phase II Competing Renewal Grant. The award of over $3.18 MM over three years will support Altor's efforts to complete a second Phase 2 clinical trial using ALT-836, an antibody-based tissue factor antagonist, as a therapy to treat patients with infection-induced acute lung injury/acute respiratory distress syndrome.
A study from the University of Minnesota Cancer Center indicates that overweight and obesity could more than double an older woman's risk of acute myelogenous leukemia (AML), an often fatal cancer of the bone marrow and blood.
A new survey carried out by the Royal Pharmaceutical Society and the UK Black Pharmacists Association has found that pharmacy teams are still not receiving adequate individual COVID-19 risk assessments.
Findings by UT Southwestern Medical Center researchers encourage men to weigh both the potential benefits and side effects of the drug finasteride before taking it to prevent prostate cancer.
› Verified 7 days ago